Overview
Beta-blockade With Landiolol in Out-of-hospital Cardiac Arrest
Status:
Recruiting
Recruiting
Trial end date:
2023-12-31
2023-12-31
Target enrollment:
0
0
Participant gender:
All
All
Summary
This study investigates the efficacy of landiolol versus placebo in patients with out-of-hospital cardiac arrest (OHCA) and refractory ventricular fibrillation (electrical storm).Phase:
Phase 1/Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Medical University of ViennaTreatments:
Landiolol
Criteria
Inclusion Criteria:- OHCA , >/=18 years of age
- 3 or more shockable rhythms (VF or pVT) and last rhythm shockable
Exclusion Criteria:
- Age > 85a
- Severe head trauma or acute active bleeding
- Known allergy or insensitivity to landiolol or another beta-blocker